Close

Ratings by William Blair (Tim Lugo)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/28/2024 Solid Biosciences SLDB New Coverage Outperform
(N/A)
14.25
(10.37)
-27.23% Details
3/12/2024 Zevra Therapeutics, Inc. ZVRA New Coverage Outperform
(N/A)
6.13
(4.80)
-21.7% Details
2/20/2024 ARS Pharmaceuticals Inc SPRY Upgrade Outperform
(Market Perform)
7.17
(9.02)
25.8% Details
2/16/2024 Kinnate Biopharma KNTE Downgrade Market Perform
(Outperform)
2.27
(2.65)
16.74% Details
1/29/2024 Abbvie ABBV Upgrade Outperform
(Market Perform)
164.40
(162.28)
-1.29% Details
12/20/2023 argenx SE ARGX Downgrade Market Perform
(Outperform)
452.58
(378.02)
-16.47% Details
12/18/2023 Allakos Inc. ALLK Upgrade Outperform
(Market Perform)
3.00
(1.11)
-63% Details
11/13/2023 Aclaris Therapeutis ACRS Downgrade Market Perform
(Outperform)
4.76
(1.21)
-74.58% Details
11/1/2023 Eyenovia EYEN New Coverage Outperform
(N/A)
1.30
(0.53)
-59.23% Details
9/21/2023 Travere Therapeutics TVTX Downgrade Market Perform
(Outperform)
12.88
(6.37)
-50.54% Details
9/20/2023 ARS Pharmaceuticals Inc SPRY Downgrade Market Perform
(Outperform)
7.44
(9.02)
21.24% Details
7/25/2023 Abbvie ABBV New Coverage Market Perform
(N/A)
143.18
(162.28)
13.34% Details
5/24/2023 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
5/10/2023 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
1/3/2023 ARS Pharmaceuticals Inc SPRY New Coverage Outperform
(N/A)
8.53
(9.02)
5.74% Details
9/9/2022 Allakos Inc. ALLK Maintain Market Perform
(N/A)
 
 
  Details
9/8/2022 Revance Therapeutic RVNC Maintain Outperform
(N/A)
 
 
  Details
8/3/2022 Sarepta Therapeutics SRPT Maintain Outperform
(Outperform)
 
 
  Details
7/22/2022 VistaGen Therapeutics VTGN Downgrade Market Perform
(Outperform)
1.07
(4.89)
357.01% Details
7/22/2022 VistaGen Therapeutics VTGN Downgrade Market Perform
(Outperform)
1.07
(1.07)
0% Details
7/13/2022 Xenon Pharmaceuticals XENE Maintain Outperform
(Outperform)
 
 
  Details
7/13/2022 9 Meter Biopharma NMTR Maintain Outperform
(Outperform)
 
 
  Details
7/13/2022 VistaGen Therapeutics VTGN Maintain Outperform
(Outperform)
 
 
  Details
6/24/2022 Sarepta Therapeutics SRPT Maintain Outperform
(Outperform)
 
 
  Details
6/23/2022 Xenon Pharmaceuticals XENE Maintain Outperform
(Outperform)
 
 
  Details
6/8/2022 VistaGen Therapeutics VTGN Maintain Outperform
(Outperform)
 
 
  Details
6/8/2022 Albireo Pharma ALBO Maintain Outperform
(Outperform)
 
 
  Details
5/26/2022 VistaGen Therapeutics VTGN Maintain Outperform
(Outperform)
 
 
  Details
5/23/2022 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(Outperform)
 
 
  Details
5/4/2022 Brickell Biotech Inc. BBI Maintain Outperform
(Outperform)
 
 
  Details
4/5/2022 Collegium Pharmaceutical COLL Maintain Outperform
(Outperform)
 
 
  Details
4/4/2022 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(Outperform)
 
 
  Details
3/29/2022 Kinnate Biopharma KNTE Maintain Outperform
(Outperform)
 
 
  Details
3/28/2022 Eagle Pharmaceuticals EGRX Maintain Outperform
(Outperform)
 
 
  Details
3/23/2022 9 Meter Biopharma NMTR Maintain Outperform
(Outperform)
 
 
  Details
3/15/2022 Brickell Biotech Inc. BBI Maintain Outperform
(Outperform)
 
 
  Details
3/9/2022 Lyra Therapeutics LYRA Maintain Outperform
(Outperform)
 
 
  Details
3/8/2022 Revance Therapeutic RVNC Maintain Outperform
(Outperform)
 
 
  Details
3/8/2022 Brickell Biotech Inc. BBI New Coverage Outperform
(N/A)
0.20
(2.35)
1075% Details
3/2/2022 Allakos Inc. ALLK Maintain Market Perform
(Market Perform)
 
 
  Details
3/1/2022 Albireo Pharma ALBO Maintain Outperform
(Outperform)
 
 
  Details
2/25/2022 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(Outperform)
 
 
  Details
2/16/2022 Allakos Inc. ALLK Maintain Market Perform
(Market Perform)
 
 
  Details
2/11/2022 VistaGen Therapeutics VTGN Maintain Outperform
(Outperform)
 
 
  Details
1/19/2022 Zogenix, Inc. ZGNX Downgrade Market Perform
(Outperform)
15.64
(26.68)
70.59% Details
1/19/2022 Revance Therapeutic RVNC Maintain Outperform
(Outperform)
 
 
  Details
12/22/2021 Allakos Inc. ALLK Downgrade Market Perform
(Outperform)
84.39
(1.11)
-98.68% Details
11/9/2021 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
10/19/2021 Atea Pharmaceuticals AVIR Maintain Outperform
(N/A)
 
 
  Details
10/11/2021 Adamas Pharmaceuticals ADMS Downgrade Market Perform
(Outperform)
4.61
(8.22)
78.31% Details
8/31/2021 Eagle Pharmaceuticals EGRX Maintain Outperform
(N/A)
 
 
  Details
7/13/2021 Kinnate Biopharma KNTE New Coverage Outperform
(N/A)
22.61
(2.27)
-89.96% Details
6/15/2021 Sage Therapeutics SAGE Downgrade Market Perform
(Outperform)
72.86
(15.44)
-78.81% Details
1/4/2021 VistaGen Therapeutics VTGN Upgrade Outperform
(Market Perform)
1.94
(4.89)
152.06% Details
11/24/2020 Atea Pharmaceuticals AVIR New Coverage Outperform
(N/A)
33.54
(3.76)
-88.79% Details
9/23/2020 9 Meter Biopharma NMTR New Coverage Outperform
(N/A)
0.69
(0.07)
-89.86% Details
6/26/2020 Zogenix, Inc. ZGNX Maintain Outperform
(N/A)
 
 
  Details
6/5/2020 Adamas Pharmaceuticals ADMS Maintain Outperform
(N/A)
 
 
  Details
6/3/2020 BVHN Maintain Outperform
(N/A)
 
 
  Details
5/26/2020 Lyra Therapeutics LYRA New Coverage Outperform
(N/A)
14.43
(5.28)
-63.41% Details
2/3/2020 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
1/8/2020 Xenon Pharmaceuticals XENE New Coverage Outperform
(N/A)
14.73
(41.30)
180.38% Details
12/10/2019 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
11/14/2019 VistaGen Therapeutics VTGN Downgrade Market Perform
(Outperform)
1.08
(4.89)
352.78% Details
10/31/2019 argenx SE ARGX Upgrade Outperform
(Market Perform)
119.14
(378.02)
217.29% Details
9/17/2019 Collegium Pharmaceutical COLL Maintain Outperform
(N/A)
 
 
  Details
8/28/2019 VistaGen Therapeutics VTGN New Coverage Outperform
(N/A)
0.64
(1.08)
68.75% Details
6/25/2019 Acer Therapeutics ACER Downgrade Market Perform
(Outperform)
19.28
(0.90)
-95.33% Details
12/20/2018 Shire SHPG Downgrade Market Perform
(Outperform)
168.73
(179.20)
6.21% Details
8/13/2018 Allakos Inc. ALLK New Coverage Outperform
(N/A)
37.27
(1.11)
-97.02% Details